PREDICTORS FOR RESPONSE TO RUXOLITINIB IN REAL-LIFE: AN OBSERVATIONAL INDEPENDENT STUDY ON 266 PATIENTS WITH MYELOFIBROSIS

被引：0

作者：

Polverelli, N. ^{[1
]}

Benevolo, G. ^{[2
]}

Palumbo, G. A. ^{[3
]}

Bonifacio, M. ^{[4
]}

Tiribelli, M. ^{[5
]}

Martino, B. ^{[6
]}

Tieghi, A. ^{[7
]}

Breccia, M. ^{[8
]}

Ibatici, A. ^{[9
]}

Crugnola, M. ^{[10
]}

Bosi, C. ^{[11
]}

Catani, L. ^{[12
]}

Scaffidi, L. ^{[13
]}

de Marchi, F. ^{[14
]}

Lazzaro, A. ^{[11
]}

Aversa, F. ^{[10
]}

Di Raimondo, F. ^{[15
]}

Vallisa, D. ^{[11
]}

Vitolo, U. ^{[16
]}

Merli, F. ^{[7
]}

Fanin, R. ^{[14
]}

Alimena, G. ^{[8
]}

Martinelli, G. ^{[17
]}

Cavo, M. ^{[17
]}

Vianelli, N. ^{[17
]}

Palandri, F. ^{[17
]}

机构：

[1] Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Citta Salute & Sci Hosp, Div Hematol, Turin, Italy

[3] AOU Policlin V Emanuele, UO Ematol, Catania, Italy

[4] Univ Verona, Dept Hematol, Verona, Italy

[5] Azienda Osped Univ Udine, Div Hematol & BMT, Udine, Italy

[6] Azienda Osped Bianchi Melacrino Morelli, Div Hematol, Reggio Di Calabria, Italy

[7] Azienda Osped Arcispedale Santa Maria Nuova, IRCSS, Div Hematol, Reggio Emilia, Italy

[8] Univ Sapienza, Div Cellular Biotechnol & Hematol, Rome, Italy

[9] Azienda Osped Univ Genova, Div Hematol, Genoa, Italy

[10] Azienda Osped Univ Parma, Div Hematol, Parma, Italy

[11] Azienda Osped Piacenza, Div Hematol, Piacenza, Italy

[12] Inst Hematol L&A Seragnoli, Bologna, Italy

[13] Univ Verona, Dept Hematol, Verona, Italy

[14] Azienda Osped Univ Udine, Div Hematol & BMT, Udine, Italy

[15] AOU Policlin V Emanuele, UO Ematol, Catania, Italy

[16] Citta Salute & Sci Hosp, Div Hematol, Turin, Italy

[17] Azienda Osped Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P672

引用

页码：266 / 267

页数：2

共 50 条

[1] Predictors for Response to Ruxolitinib in Real-Life: An Observational Independent Study on 408 Patients with Myelofibrosis
Palandri, Francesca
Palumbo, Giuseppe A.
Bonifacio, Massimiliano
Tiribelli, Mario
Benevolo, Giulia
Martino, Bruno
Abruzzese, Elisabetta
D'Adda, Mariella
Polverelli, Nicola
Bergamaschi, Micaela
Tieghi, Alessia
Cavazzini, Francesco
Ibatici, Adalberto
Crugnola, Monica
Bosi, Costanza
Latagliata, Roberto
Di Veroli, Ambra
Scaffidi, Luigi
De Marchi, Federico
Cerqui, Elisa
Anaclerico, Barbara
Di Raimondo, Francesco
Vitolo, Umberto
Lemoli, Roberto M.
Fanin, Renato
Merli, Francesco
Russo, Domenico
Cuneo, Antonio
Cavo, Michele
Vianelli, Nicola
Breccia, Massimo
BLOOD, 2016, 128 (22)
[2] Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib-A Real-Life Longitudinal Study
Stoeva, Vera
Mihaylov, Georgi
Mitov, Konstantin
Petrova, Guenka
Tachkov, Konstantin
CANCERS, 2023, 15 (20)
[3] Real-life ruxolitinib experience in intermediate-risk myelofibrosis
Arikan, Fatma
Toptas, Tayfur
Atagunduz, Isik Kaygusuz
Ercan, Tarik
Oruc, Ozen
Yilmaz, Fergun
Tuglular, Tulin
BLOOD RESEARCH, 2021, 56 (04) : 322 - 331
[4] Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis
Palandri, Francesca
Palumbo, Giuseppe Alberto
Bonifacio, Massimiliano
Tiribelli, Mario
Benevolo, Giulia
Martino, Bruno
Abruzzese, Elisabetta
D'Adda, Mariella
Polverelli, Nicola
Bergamaschi, Micaela
Tieghi, Alessia
Cavazzini, Francesco
Ibatici, Adalberto
Crugnola, Monica
Bosi, Costanza
Latagliata, Roberto
Di Veroli, Ambra
Scaffidi, Luigi
de Marchi, Federico
Cerqui, Elisa
Anaclerico, Barbara
De Matteis, Giovanna
Spinsanti, Marco
Sabattini, Elena
Catani, Lucia
Aversa, Franco
Di Raimondo, Francesco
Vitolo, Umberto
Lemoli, Roberto Massimo
Fanin, Renato
Merli, Francesco
Russo, Domenico
Cuneo, Antonio
Reggiani, Maria Letizia Bacchi
Cavo, Michele
Vianelli, Nicola
Breccia, Massimo
ONCOTARGET, 2017, 8 (45) : 79073 - 79086
[5] Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project
Coltro, Giacomo
Sant'Antonio, Emanuela
Palumbo, Giuseppe A.
Mannelli, Francesco
De Stefano, Valerio
Ruggeri, Marco
Elli, Elena M.
Zanotti, Roberta
Borsani, Oscar
Bertozzi, Irene
Duminuco, Andrea
Betti, Silvia
Carli, Giuseppe
Cavalca, Fabrizio
Tanasi, Ilaria
Rumi, Elisa
Randi, Maria L.
Garibaldi, Bruno
Loscocco, Giuseppe G.
Guglielmelli, Paola
Vannucchi, Alessandro M.
CANCER MEDICINE, 2023, 12 (07): : 8166 - 8171
[6] Short and Mid-Term Predictors of Response to OnabotulinumtoxinA: Real-Life Experience Observational Study
Alpuente, Alicia
Gallardo, Victor Jose
Torres-Ferrus, Marta
Alvarez-Sabin, Jose
Pozo-Rosich, Patricia
HEADACHE, 2020, 60 (04): : 677 - 685
[7] Efficacy and Predictors of Response to Fampridine in a Sample of Patients with Multiple Sclerosis: a Real-Life Study
Martinez, Elisa
Robles Sanchez, Miguel Angel
Horno, Rosalia
Castillo-Justribo, Joaquin
Vidal-Jordana, Angela
Zabalza, Ana
Rodriguez, Breogan
Vilaseca, Andreu
Arrambide, Georgina
Pappolla, Agustin
Midaglia, Luciana
Galan, Ingrid
Arino, Helena
Carvajal, Rene
Mongay-Ochoa, Neus
Cobo Calvo, Alvaro
Comabella, Manuel
Sastre-Garriga, Jaume
Tintore, Mar
Montalban, Xavier
Rio, Jordi
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 120 - 121
[8] Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study
Sotiropoulos, Damianos
Papadopoulos, Vassilios
Dimou, Maria
Kyriakou, Despoina
Papaioannou, George
Karavalakis, George
Papadakis, Emmanuel
Palasopoulou, Maria
Banti, Anastasia
Kourelis, Taxiarchis
Kouraklis, Alexandra
Marinakis, Theodoros
Viniou, Nora-Athina
Hatzimichael, Eleftheria
Vasilatou, Diamantina
Vassilopoulos, George
Panayiotidis, Panayiotis
Anagnostopoulos, Achilles
BLOOD, 2015, 126 (23)
[9] Predictors of vedolizumab response to induction: Real-life experience
Gutierrez, A.
Sempere, L.
Belvis, M.
Vazquez, J. M.
Laveda, R.
Garcia, M.
Arguelles-Arias, F.
Pallares, H.
Castro, L.
Gomez, E.
Maldonado, B.
JOURNAL OF CROHNS & COLITIS, 2018, 12 : S297 - S297
[10] Treatment response according to small airway phenotypes: a real-life observational study
Marth, Katharina
Spinola, Monica
Kisiel, Judith
Woergetter, Christian
Petrovic, Milos
Pohl, Wolfgang
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (03) : 200 - 210

← 1 2 3 4 5 →